Skip to main content
. 2022 May 30;50(10):5577–5598. doi: 10.1093/nar/gkac407

Table 1.

Clinical Information table corresponding to the HIV-1 infected study participants

Donor 1 Donor 2 Donor 3 Donor 4 Donor 5 Donor 6 Donor 7 Donor 8 Donor 9 Donor 10
Symbol graphic file with name gkac407figu1.jpg graphic file with name gkac407figu2.jpg graphic file with name gkac407figu3.jpg graphic file with name gkac407figu4.jpg graphic file with name gkac407figu5.jpg graphic file with name gkac407figu6.jpg graphic file with name gkac407figu7.jpg graphic file with name gkac407figu8.jpg graphic file with name gkac407figu9.jpg graphic file with name gkac407figu10.jpg
Sex F M M M M M M M M M
Time from HIV-1 diagnosis to leuk. (months) 55 85 52 86 108 19 384 264 77 250
ART initiated during acute HIV-1 No No Yes (Fiebig 6) Yes (Fiebig 6) No Yes (Fiebig 4) No No No No
Time on ART (months) 55 72 52 86 81 19 288 204 77 243
Time with continues HIV-1 RNA < 50 copies/ml (months) >12 >12 >12 >12 >12 >12 >12 >12 >12 >12
CD4+ at leukapheresis (mm3) 620 490 1540 990 970 870 570 750 950 470